Organon & (OGN)
Healthcare · Drug Manufacturers - General
4 members of Congress have disclosed 4 trades in Organon & (OGN) since 2021: 1 buy and 3 sales. The most recent was disclosed on Aug 10, 2026.
- Trades disclosed
- 4
- Members trading
- 4
- Buys / sells
- 1 / 3
- Reported value
- $4K–$60K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at OGN
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
OGN: Company disclosure
Filed 8-K for an event or period dated 2026-10-30. Company disclosure.
OGN: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
Who traded OGN
- Rep. Kevin Hern (R-OK-1)0 buys · 1 sale01Aug 10, 2026
- Sen. Gary C. Peters (D-MI)0 buys · 1 sale01Nov 24, 2025
- Rep. Ro Khanna (D-CA-17)1 buy · 0 sales10Nov 8, 2023
- Sen. John W. Hickenlooper (D-CO)0 buys · 1 sale01Jul 9, 2021
All trades
- Aug 10, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Aug 5, 2026 · disclosed Aug 10, 2026 · Joint
- Nov 24, 2025$1K–$15K
Sen. Gary C. Peters (D-MI)
$1K–$15K · Traded Jul 10, 2025 · disclosed Nov 24, 2025 · filed 137 days later
- Nov 8, 2023$1K–$15K
- Jul 9, 2021$1K–$15K
Sen. John W. Hickenlooper (D-CO)
$1K–$15K · Traded Jun 28, 2021 · disclosed Jul 9, 2021
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.